Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.

导出原文传递

翻译打印收藏纠错

作者： Josep F,Nomdedéu ^[1] ; Eulalia,Puigdecanet ^[2] ; Elena,Bussaglia ^[1] ; Juan José,Hernández ^[3] ; Maite,Carricondo ^[1] ; Camino,Estivill ^[1] ; Josep Maria,Martí-Tutusaus ^[4] ; Mar,Tormo ^[5] ; Lurdes,Zamora ^[6] ; Elena,Serrano ^[7] ; Granada,Perea ^[8] ; Maria Paz Queipo,de Llano ^[9] ; Antoni,García ^[10] ; Isabel,Sánchez-Ortega ^[11] ; Josep Maria,Ribera ^[6] ; Lara,Nonell ^[2] ; Anna,Aventin ^[1] ; Francesc,Solé ^[6] ; Maria Salut,Brunet ^[1] ; Jorge,Sierra ^[1]

作者单位： Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. ^[1] Servei d'Analisi de Microarrays, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain. ^[2] Laboratori de Referència de Catalunya, Barcelona, Spain. ^[3] Hematology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain. ^[4] Hematology Department, Hospital Clínico de Valencia, INCLIVA, Valencia, Spain. ^[5] Hematology Department, Institut Recerca contra la Leucemia Josep Carreras (IJC), ICO Badalona Hospital Germans Trias i Pujol, Badalona, Spain. ^[6] Bioinformatic Platform, IIB Sant Pau, Barcelona, Spain. ^[7] Laboraotory Service, UDIAT-CD, Parc Taulí Hospital Universitari, Sabadell, Spain. ^[8] Hematology Department, Hospital Virgen de la Victoria, Màlaga, Spain. ^[9] Hematology Department, Hospital Arnau de Vilanova, Lleida, Spain. ^[10] Hematology Department, Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain. ^[11]

关键词 acute myeloid leukaemia gene expression profiling leukaemia diagnostic molecular genetics